TMO Stock Recent News

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced Karen S. Lynch has been elected to its board of directors, effective February 19, 2025. The appointment brings the total number of Thermo Fisher board members to 12. Ms. Lynch is a seasoned health care executive with over three decades of experience in the industry. As the former president and chief executive officer of CVS Health Corporation (NYSE: CVS), a leading hea.

Thermo Fisher's Invitrogen EVOS S1000 Spatial Imaging System addresses the limitations of current fluorescent microscopy technologies.

DELRAY BEACH, Fla., Feb. 13, 2025 /PRNewswire/ -- The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 billion by 2029. Major drivers of market growth include rising burden of infectious diseases and rapid technological advancements in molecular diagnostics. The increased incidence of emerging infectious diseases and antibiotic-resistant infections leads to greater demand for accurate and reliable diagnostics. In addition, there are rapid advances in the efficiency of molecular testing techniques, such as PCR and next-generation sequencing, which have improved diagnostic capabilities. These provide results that are more sensitive and at a faster speed, and allow for the simultaneous identification of multiple pathogens, which becomes vital in handling complex and continually changing infectious disease threats. These are some of the major co

NEW YORK, Feb. 13, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The ultraviolet (UV) sensor market and it is set to grow by USD 7.57 billion from 2025 to 2029. However, the growth momentum will progressing at a CAGR of almost 26.1% during the forecast period, according to Technavio. The ultraviolet (uv) sensor market is fragmented, and the vendors are seeking strong partnerships with automotive, industrial, and commercial companies to compete in the market. Adafruit Industries LLC, Apogee Instruments Inc., Balluff GmbH, Broadcom Inc., Davis Instruments Corp., GaNo Optoelectronics Inc., Genicom Co. Ltd., LAPIS Semiconductor Co. Ltd., Panasonic Holdings Corp., sglux GmbH, Silicon Laboratories Inc., Skye Instruments Ltd., Solar Light Co. Inc., STMicroelectronics NV, TRI TRONICS, UV-Technik Speziallampen GmbH, Vernier Software and Technology LLC, Vishay Intertechnology Inc., Xylem Inc., and ZED Ziegler Electronic Devices GmbH are some of the major market participants -

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Invitrogen™ EVOS™ S1000 Spatial Imaging System. This advanced system addresses the limitations of current fluorescent microscopy technologies by enabling researchers to generate a multiplexed high-quality image for multiple samples within several hours, thereby lowering the barrier to entry into spatial tissue proteomics. The EVOS S1000, from Thermo Fisher Scientific's innov.

Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Laboratory Supplies Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering. The global laboratory supplies market is projected to grow at a CAGR of 7.44% over the forecast period, increasing from US$47.531 billion in 2025 to US$68.044 billion by 2030. The laboratory supply market is expanding due to advancements in science and technology, along with increased research and development (R&D) activities. In the healthcare and pharmaceutical sectors, the rising demand for high-quality, specialized supplies - particularly in genomics, proteomics, and biotechnology - further drives the growth of this market. Additionally, the emphasis on laboratory automation and sustainability has led to the development of more efficient, eco-friendly, and cost-effective laboratory products. Key Drivers of the Laboratory Supplies Market

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. announced the launch of the international CorEvitas Adolescent Alopecia Areata (AA) Registry.

Thermo Fisher returned to growth in 4Q 2024 across all segments, and 2025 EPS growth is projected at 6.6% supported by margin expansion. Despite rich industry valuations, Thermo trades at a discount to peers like Danaher, supported by its unique scale and breadth of offerings. Thermo looks fairly valued based on a conservative DCF analysis, but its industry leadership position and relative valuation to peers warrant an upgrade to Buy.

Shares of Thermo Fisher Scientific (TMO) rose Thursday after the medical device maker's fourth-quarter results topped analysts' estimates.

In the fourth quarter of 2024, TMO continued to advance its growth strategy and trusted partner status with customers.